RU2478367C2 - Стабильная композиция (варианты), лекарственное средство (варианты) и способы лечения и профилактики кожных инфекций и инфекций кожных структур, вызванных бактериями, заболеваний, передающихся половым путем, и инфекций половых путей, вызванных бактериями, и инфекций носоглотки, вызванных бактериями, у человека или животного - Google Patents

Стабильная композиция (варианты), лекарственное средство (варианты) и способы лечения и профилактики кожных инфекций и инфекций кожных структур, вызванных бактериями, заболеваний, передающихся половым путем, и инфекций половых путей, вызванных бактериями, и инфекций носоглотки, вызванных бактериями, у человека или животного Download PDF

Info

Publication number
RU2478367C2
RU2478367C2 RU2011119764/15A RU2011119764A RU2478367C2 RU 2478367 C2 RU2478367 C2 RU 2478367C2 RU 2011119764/15 A RU2011119764/15 A RU 2011119764/15A RU 2011119764 A RU2011119764 A RU 2011119764A RU 2478367 C2 RU2478367 C2 RU 2478367C2
Authority
RU
Russia
Prior art keywords
infections
bacteria
composition according
caused
skin
Prior art date
Application number
RU2011119764/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2011119764A (ru
Inventor
Антонио ГУЛЬЕТТА
Мануэль РАГА
Бенхамин САНТОС
Кристина ТАРРАГО
Original Assignee
Феррер Интернасионал С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40291273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2478367(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Феррер Интернасионал С.А. filed Critical Феррер Интернасионал С.А.
Publication of RU2011119764A publication Critical patent/RU2011119764A/ru
Application granted granted Critical
Publication of RU2478367C2 publication Critical patent/RU2478367C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2011119764/15A 2008-10-17 2009-10-16 Стабильная композиция (варианты), лекарственное средство (варианты) и способы лечения и профилактики кожных инфекций и инфекций кожных структур, вызванных бактериями, заболеваний, передающихся половым путем, и инфекций половых путей, вызванных бактериями, и инфекций носоглотки, вызванных бактериями, у человека или животного RU2478367C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08166933A EP2177208A1 (en) 2008-10-17 2008-10-17 Pharmaceutical topical compositions
EP08166933.5 2008-10-17
PCT/EP2009/063625 WO2010043717A2 (en) 2008-10-17 2009-10-16 Pharmaceutical topical compositions

Publications (2)

Publication Number Publication Date
RU2011119764A RU2011119764A (ru) 2012-11-27
RU2478367C2 true RU2478367C2 (ru) 2013-04-10

Family

ID=40291273

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011119764/15A RU2478367C2 (ru) 2008-10-17 2009-10-16 Стабильная композиция (варианты), лекарственное средство (варианты) и способы лечения и профилактики кожных инфекций и инфекций кожных структур, вызванных бактериями, заболеваний, передающихся половым путем, и инфекций половых путей, вызванных бактериями, и инфекций носоглотки, вызванных бактериями, у человека или животного

Country Status (23)

Country Link
US (4) US9180200B2 (cg-RX-API-DMAC7.html)
EP (3) EP2177208A1 (cg-RX-API-DMAC7.html)
JP (2) JP5509209B2 (cg-RX-API-DMAC7.html)
KR (3) KR20160025034A (cg-RX-API-DMAC7.html)
CN (1) CN102186460B (cg-RX-API-DMAC7.html)
AR (1) AR073901A1 (cg-RX-API-DMAC7.html)
AU (1) AU2009305360B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0920355B8 (cg-RX-API-DMAC7.html)
CA (2) CA2738384C (cg-RX-API-DMAC7.html)
CL (2) CL2011000848A1 (cg-RX-API-DMAC7.html)
CY (1) CY1114838T1 (cg-RX-API-DMAC7.html)
DK (1) DK2344130T3 (cg-RX-API-DMAC7.html)
ES (1) ES2437967T3 (cg-RX-API-DMAC7.html)
MX (2) MX338029B (cg-RX-API-DMAC7.html)
NL (1) NL300884I2 (cg-RX-API-DMAC7.html)
PH (1) PH12014502425A1 (cg-RX-API-DMAC7.html)
PL (1) PL2344130T3 (cg-RX-API-DMAC7.html)
PT (1) PT2344130E (cg-RX-API-DMAC7.html)
RU (1) RU2478367C2 (cg-RX-API-DMAC7.html)
SI (1) SI2344130T1 (cg-RX-API-DMAC7.html)
TW (2) TWI504418B (cg-RX-API-DMAC7.html)
UY (1) UY32187A (cg-RX-API-DMAC7.html)
WO (1) WO2010043717A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012028720A2 (pt) 2010-05-10 2016-07-19 Segetis Inc alquil cetal ésteres com dispersantes e agentes deslizantes para partículas sólidas, métodos de fabricação e suas utilizações
US9458414B2 (en) 2012-09-21 2016-10-04 Gfbiochemicals Limited Cleaning, surfactant, and personal care compositions
DE102013226507B4 (de) * 2013-12-18 2022-05-05 Ashland Industries Europe Gmbh Konzentrat umfassend Ferulasäureethylester und Arylalkanol und dessen Verwendung
ES2661000T3 (es) 2014-09-12 2018-03-27 Antibiotx A/S Uso antibacteriano de salicilanilidas halogenadas
WO2016129657A1 (ja) * 2015-02-13 2016-08-18 マルホ株式会社 ピリドンカルボン酸系誘導体を含有する外用剤
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
JP7347915B2 (ja) * 2016-04-28 2023-09-20 マルホ株式会社 抗菌剤
WO2018048042A1 (ko) * 2016-09-12 2018-03-15 주식회사 가나씨앤에이치 글리세린 젖산 에스테르를 유효성분으로 하는 방부 및 항균용 외용제 조성물
WO2018101443A1 (ja) * 2016-12-01 2018-06-07 マルホ株式会社 医療用皮膚外用剤
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN113712913A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种奥泽沙星混悬滴眼液组合物
US11724077B2 (en) * 2021-07-28 2023-08-15 Subhash Dhawan Therapeutic swabs for treating upper respiratory infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124353C1 (ru) * 1994-12-19 1999-01-10 Л'Ореаль Фармацевтическая композиция местного применения и способ ее получения
EP1941880A1 (en) * 2005-08-01 2008-07-09 MARUHO Co., Ltd. Lotion preparation containing pyridonecarboxylic acid derivative

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243827A (ja) * 1991-01-25 1992-08-31 Sumitomo Pharmaceut Co Ltd プロスタグランジン誘導体含有溶解型軟膏剤
JP3174590B2 (ja) * 1991-04-04 2001-06-11 テルモ株式会社 ステロイド軟膏剤
JP3162335B2 (ja) * 1998-03-11 2001-04-25 ユーナイテッド ネイションズ デベロップメント プログラム 皮膚真菌感染症治療用の植物薬剤、その製造法と用途
WO1999051588A1 (en) 1998-04-06 1999-10-14 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
CA2376210A1 (en) * 1999-06-08 2000-12-14 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
JP4293755B2 (ja) 2001-03-26 2009-07-08 富山化学工業株式会社 ピリドンカルボン酸系化合物を含有する皮膚外用剤
JP4384402B2 (ja) 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
JP4875979B2 (ja) 2004-03-31 2012-02-15 富山化学工業株式会社 難溶性薬物の微粒子分散液およびその製造方法
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
JP5112669B2 (ja) 2005-09-30 2013-01-09 富山化学工業株式会社 難溶性薬物のナノ微粒子を含有する水性懸濁液剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124353C1 (ru) * 1994-12-19 1999-01-10 Л'Ореаль Фармацевтическая композиция местного применения и способ ее получения
EP1941880A1 (en) * 2005-08-01 2008-07-09 MARUHO Co., Ltd. Lotion preparation containing pyridonecarboxylic acid derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
C.TARRAGO et al. «IN VITRO ANTIBACTERIAL ACTIVITY COMPARED WITH OTHER ANTIBACTERIAL AGENTS AGAINST CLINICAL ISOLATES FROM WOUND INFECTIONS AND SELECTIONS AND SELECTION OF RESISTANT MUTANTS» 15.09.2007. C.TARRAGO et al. PRECLINICAL IN VITRO AND IN VIVO ABSORPTION EVALUTION OF OZENOXACIN: A NOVEL TOPICAL NON-FLUORINATED QUINOLONE» 15.09.2007. *

Also Published As

Publication number Publication date
CA2738384A1 (en) 2010-04-22
EP2344130A2 (en) 2011-07-20
EP2344130B9 (en) 2013-11-20
NL300884I2 (nl) 2017-08-31
KR101682256B1 (ko) 2016-12-02
BRPI0920355B1 (pt) 2020-04-07
CA2738384C (en) 2014-07-08
CN102186460B (zh) 2013-06-12
TWI504418B (zh) 2015-10-21
US20110263646A1 (en) 2011-10-27
US9399014B2 (en) 2016-07-26
PT2344130E (pt) 2013-12-09
SI2344130T1 (sl) 2013-12-31
BRPI0920355B8 (pt) 2021-05-25
CL2015002899A1 (es) 2016-05-13
JP5509209B2 (ja) 2014-06-04
MX2011004052A (es) 2011-05-10
PH12014502425A1 (en) 2015-09-07
EP2177208A1 (en) 2010-04-21
WO2010043717A2 (en) 2010-04-22
HK1161552A1 (en) 2012-07-27
ES2437967T3 (es) 2014-01-15
US20160030338A1 (en) 2016-02-04
CN102186460A (zh) 2011-09-14
CA2822167C (en) 2015-09-01
BRPI0920355A2 (pt) 2016-03-15
KR20110071086A (ko) 2011-06-28
US9180200B2 (en) 2015-11-10
US20140187578A1 (en) 2014-07-03
US10022363B2 (en) 2018-07-17
MX338029B (es) 2016-03-31
CL2011000848A1 (es) 2012-03-30
US20160243104A1 (en) 2016-08-25
JP2014088456A (ja) 2014-05-15
JP5873120B2 (ja) 2016-03-01
WO2010043717A3 (en) 2010-07-29
EP2570117A1 (en) 2013-03-20
UY32187A (es) 2010-04-30
CY1114838T1 (el) 2016-12-14
CA2822167A1 (en) 2010-04-22
EP2344130B1 (en) 2013-09-04
AU2009305360A1 (en) 2010-04-22
KR20160025034A (ko) 2016-03-07
AU2009305360B2 (en) 2015-04-09
PL2344130T3 (pl) 2014-03-31
TW201511779A (zh) 2015-04-01
RU2011119764A (ru) 2012-11-27
JP2012505867A (ja) 2012-03-08
DK2344130T3 (da) 2013-12-09
AR073901A1 (es) 2010-12-09
TW201018497A (en) 2010-05-16
KR20160116353A (ko) 2016-10-07

Similar Documents

Publication Publication Date Title
RU2478367C2 (ru) Стабильная композиция (варианты), лекарственное средство (варианты) и способы лечения и профилактики кожных инфекций и инфекций кожных структур, вызванных бактериями, заболеваний, передающихся половым путем, и инфекций половых путей, вызванных бактериями, и инфекций носоглотки, вызванных бактериями, у человека или животного
CN108883309B (zh) 包含卤代水杨酰苯胺的非水性局部组合物
CN116251084A (zh) S-盐酸氯胺酮的药物组合物
CA2899206A1 (en) Compositions for transdermal delivery of mtor inhibitors
TWI751136B (zh) 含多佐胺與溴莫尼定之醫藥組成物
HK1161552B (en) Pharmaceutical topical compositions
AU2023255052A1 (en) Topical montelukast formulations
JP4541661B2 (ja) 消毒および／または殺菌用組成物
JP6820587B2 (ja) 水性固形軟膏
RU2486905C1 (ru) Средство для лечения мастита у животных
KR20220032486A (ko) 에멀젼 제형의 소독제 조성물
AU2020365665A1 (en) External preparation for treating epilepsy or autism spectrum disorder
JP2021004267A (ja) 医薬組成物